BIOSECURE Act

The BIOSECURE Act prohibits U.S. federal agencies from contracting for or using biotechnology equipment and services from designated "biotechnology companies of concern," such as BGI, MGI, Complete Genomics, WuXi AppTec, and WuXi Biologics, and bans federal funds for these purposes. It requires the Office of Management and Budget to create and update a list of these companies based on national security risks, with implementation phased in over 60-180 days after regulations are issued. Exceptions include intelligence activities, overseas health care for U.S. personnel, and publicly available multiomic data, while limited waivers for national security or overseas health care are permitted with congressional notification. The law does not require new funding and mandates annual reviews of the designated companies.